The classification concept of the ESC Working Group on Myocardial and Pericardial Diseases for dilated cardiomyopathy

Herz

Volumn 32, Issue 6, 2007, Pages 446-451

  Kaski, Juan Pablo ^c   Elliott, Perry ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c NONE

Author keywords

Dilated cardiomyopathy; ESC and AHA cardiomyopathy classifications; Myocarditis

Indexed keywords

DESMIN; DYSTROPHIN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1; MYOSIN HEAVY CHAIN BETA; TROPOMYOSIN; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADENOVIRUS; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS; DIAGNOSTIC PROCEDURE; ERYTHEMA INFECTIOSUM; GENE MUTATION; GENETIC DISORDER; HUMAN; HYPERTENSION; INBORN ERROR OF METABOLISM; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; MORPHOLOGY; MYOCARDIAL DISEASE; MYOCARDITIS; NONHUMAN; PERICARDIAL DISEASE; POLYMERASE CHAIN REACTION; SHORT SURVEY; VALVULAR HEART DISEASE; WORLD HEALTH ORGANIZATION; X CHROMOSOME LINKED DISORDER;

CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; HUMANS; PERICARDITIS; PERICARDIUM;

EID: 34748868947     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-007-3045-5     Document Type: Short Survey

References (59)

1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
2. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-16.
3. Thiene G, Corrado D, Basso C. Cardiomyopathies: is it time for a molecular classification? Eur Heart J 2004;25:1772-5.
4. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2007:in press.
5. Mestroni L. Dilated cardiomyopathy: a genetic approach. Heart 1997;77:185-8.
6. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000;106:655-62.
7. Barresi R, Di Blasi C, Negri T, et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet 2000;37:102-7.
8. Goldfarb LG, Park KY, Cervenakova L, et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998;19:402-3.
9. Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999;100:461-4.
10. Olson TM, Michels VV, Thibodeau SN, et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-2.
11. Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000;343:1688-96.
12. Kaski JP, Burch M, Elliott PM. Mutations in the cardiac troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood. Cardiol Young 2007:in press.
13. Olson TM, Kishimoto NY, Whitby FG, et al. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001;33:723-32.
14. Brodsky GL, Muntoni F, Miocic S, et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000;101:473-6.
15. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999;341:1715-24.
16. Kass S, MacRae C, Graber HL, et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 1994;7:546-51.
17. Cohen N, Muntoni F. Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 2004;90:835-41.
18. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867-76.
19. Berko BA, Swift M. X-linked dilated cardiomyopathy. N Engl J Med 1987;316:1186-91.
20. Towbin JA, Hejtmancik JF, Brink P, et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993;87:1854-65.
21. Muntoni F, Cau M, Ganau A, et al. Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993;329:921-5.
22. Campbell KP. Three muscular dystrophies: loss of cytoskeleton- extracellular matrix linkage. Cell 1995;80:675-9.
23. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-28.
24. Kaprielian RR, Stevenson S, Rothery SM, et al. Distinct patterns of dystrophin organization in myocyte sarcolemma and transverse tubules of normal and diseased human myocardium. Circulation 2000;101:2586-94.
25. Meng H, Leddy JJ, Frank J, et al. The association of cardiac dystrophin with myofibrils/Z-disc regions in cardiac muscle suggests a novel role in the contractile apparatus. J Biol Chem 1996;271:12364-71.
26. Barth PG, Scholte HR, Berden JA, et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 1983;62:327-55.
27. Kelley RI, Cheatham JP, Clark BJ, et al. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 1991;119:738-47.
28. Bione S, D'Adamo P, Maestrini E, et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 1996;12:385-9.
29. Bleyl SB, Mumford BR, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997;61:868-72.
30. D'Adamo P, Fassone L, Gedeon A, et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 1997;61:862-7.
31. Brega A, Narula J, Arbustini E. Functional, structural, and genetic mitochondrial abnormalities in myocardial diseases. J Nucl Cardiol 2001;8:89-97.
32. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
33. Noutsias M, Seeberg B, Schultheiss HP, et al. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 1999;99:2124-31.
34. Maisch B, Richter A, Sandmoller A, et al. Inflammatory dilated cardiomyopathy (DCMI). Herz 2005;30:535-44.
35. Maisch B, Richter A, Koelsch S, et al. Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy. Herz 2006;31:881-90.
36. Caforio AL, Keeling PJ, Zachara E, et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994;344:773-7.
37. Caforio AL, Mahon NJ, Tona F, et al. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002;4:411-7.
38. Schowengerdt KO, Ni J, Denfield SW, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997;96:3549-54.
39. Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997;78:539-43.
40. Kuhl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005;111:887-93.
41. Fujioka S, Kitaura Y, Ukimura A, et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000;36:1920-6.
42. Baboonian C, McKenna W. Eradication of viral myocarditis: is there hope? J Am Coll Cardiol 2003;42:473-6.
43. Dunn JJ, Chapman NM, Tracy S, et al. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region. J Virol 2000;74:4787-94.
44. Badorff C, Lee GH, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999;5:320-6.
45. Berkovich S, Rodriguez-Torres R, Lin JS. Virologic studies in children with acute myocarditis. Am J Dis Child 1968;115:207-12.
46. Akhtar N, Ni J, Stromberg D, et al. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation 1999;99:2011-8.
47. Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 2003;60:11-25.
48. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994;90:330-9.
49. Shimizu C, Rambaud C, Cheron G, et al. Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis. Pediatr Infect Dis J 1995;14:584-8.
50. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42:466-72.
51. Klein RM, Jiang H, Niederacher D, et al. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol 2004;93:300-9.
52. Munro K, Croxson MC, Thomas S, et al. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatr Cardiol 2003;24:473-5.
53. Dettmeyer R, Kandolf R, Baasner A, et al. Fatal parvovirus B19 myocarditis in an 8-year-old boy. J Forensic Sci 2003;48:183-6.
54. Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol 2001;32:342-5.
55. Rohayem J, Dinger J, Fischer R, et al. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 2001;39:4585-7.
56. Zack F, Klingel K, Kandolf R, et al. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection. Forensic Sci Int 2005;155:13-7.
57. Hofman P, Drici MD, Gibelin P, et al. Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J 1993;70:376-81.
58. Herskowitz A, Wu TC, Willoughby SB, et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 1994;24:1025-32.
59. Barbaro G, Di LG, Grisorio B, et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998;339:1093-9.